ENTRY       D07080                      Drug
NAME        Vildagliptin (JAN/USAN/INN);
            Equa (TN);
            Galvus (TN)
FORMULA     C17H25N3O2
EXACT_MASS  303.1947
MOL_WEIGHT  303.3993
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01601  DPP-4 inhibitor
REMARK      Therapeutic category: 3969
            ATC code: A10BH02
            Product: D07080<JP>
            Product (mixture): D10743<JP>
EFFICACY    Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor
TARGET      DPP4 (CD26) [HSA:1803] [KO:K01278]
  PATHWAY   hsa04974(1803)  Protein digestion and absorption
INTERACTION  
STR_MAP     map07051  Antidiabetics
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
                 A10BH02 Vildagliptin
                  D07080  Vildagliptin (JAN/USAN/INN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               396  Antidiabetic agents
                3969  Others
                 D07080  Vildagliptin (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01601  DPP-4 inhibitor
                D07080  Vildagliptin
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01601  DPP-4 inhibitor
               D07080  Vildagliptin
              DG02044  Hypoglycemic agent
               D07080  Vildagliptin
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Peptidyl-peptidases
                DPP4 (CD26)
                 D07080  Vildagliptin (JAN/USAN/INN) &lt;JP&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07080
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D07080
DBLINKS     CAS: 274901-16-5
            PubChem: 51091422
            LigandBox: D07080
            NIKKAJI: J2.160.644H
ATOM        22
            1   C1z C    16.8876  -17.1565
            2   C1x C    16.1956  -18.5404
            3   C1y C    16.1956  -19.7858
            4   C1y C    15.7113  -19.0939
            5   C1z C    17.9947  -19.0939
            6   C1x C    14.6042  -20.2010
            7   C1x C    17.3027  -20.8237
            8   C1x C    15.7113  -17.7793
            9   C1x C    16.8876  -19.7166
            10  C1x C    17.9947  -17.7793
            11  N1b N    16.8876  -15.8419
            12  O1a O    19.1890  -18.3949
            13  C1b C    18.0860  -15.1499
            14  C5a C    19.2677  -15.8324
            15  O5a O    19.2678  -17.2254
            16  N1y N    20.4413  -15.1547
            17  C1x C    20.8738  -16.4560
            18  C1x C    22.2327  -16.4309
            19  C1x C    22.6287  -15.1307
            20  C1y C    21.5145  -14.3523
            21  C3b C    21.4915  -12.9362
            22  N3a N    21.5178  -11.5519
BOND        25
            1     1   2 1
            2     2   3 1
            3     8   4 1
            4     4   9 1
            5     9   5 1
            6     5  10 1
            7    10   1 1
            8     1   8 1
            9     3   6 1
            10    3   7 1
            11    4   6 1
            12    5   7 1
            13    1  11 1
            14    5  12 1
            15   11  13 1
            16   13  14 1
            17   14  15 2
            18   14  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22   19  20 1
            23   16  20 1
            24   20  21 1 #Down
            25   21  22 3
///
